Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Israel's Together to buy control of German cannabis customer

Published 2018-08-29, 11:15 a/m
Updated 2018-08-29, 11:20 a/m
© Reuters.  Israel's Together to buy control of German cannabis customer

JERUSALEM, Aug 29 (Reuters) - Together Pharma TGTR.TA, which produces medical cannabis, said on Wednesday it had signed a deal to buy a controlling 50.01 percent stake in an unnamed German company, which is one of its customers, for 2 million euros.

Together said it had already signed an agreement to supply about 12.5 tonnes of medical cannabis worth up to 50 million euros ($58 million) to the German company, which also holds a R&D licence for medical cannabis in Germany.

Together said it would finance the deal from cash and assets, which will be recorded as an owner's loan. It said the parties will work towards signing a final deal within 90 days.

It estimated that once the deal is final, it will be able to sell its produce at a price that is currently about 10-12 euros per gram of medical cannabis in Germany through direct sales since the German company has a distribution agreement with 100 pharmacies.

The price in Europe per gram of medical cannabis is relatively high compared with the price in North America and stems from expectation for high demand, due to regulatory proceedings as well as low supply of produce throughout Europe, Together said.

The German firm, Together said, expects to receive an import and distribution licence for medial cannabis in Germany next month.

"On completion of the deal, Together will operate throughout the value supply chain in the cannabis sector – from R&D of unique strains as IP, through cultivation, manufacturing products, marketing and distribution and on to reaching the end-user customer," said Together CEO Nissim Bracha.

"Germany is the first substantial anchor for our operations in Europe, while we are setting up a farm for additional cultivation outside of Israel, in Europe, from where we can supply medical cannabis produce to Germany and other countries in the region."

Together last month signed a deal with an entity in the European Union to set up 30,000 square metres of greenhouses and a processing facility for the export of medical cannabis from Europe. It has said it would seek to set up additional farms outside of Israel since it had yet to receive an export licence from the Israeli government.

($1 = 0.8570 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.